FDA
-
-
-
-
-
-
-
Theravance Biopharma to Participate in Upcoming Investor Conferences
-
-
-
-
-
-
-
FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'
-
-
-
-
-
-
-
Theravance Biopharma to Participate in an Upcoming Investor Conference
-
-
-
-
-
-
-
Theravance Biopharma, Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Theravance Biopharma to Participate in an Upcoming Investor Conference
-
-
-
-
-
-
-
Theravance Biopharma (TBPH) Announces Publication of YUPELRI Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease
-
-
-
-
-
-
-
Theravance Biopharma to Participate in an Upcoming Investor Conference
-
323,580 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

